Mirae Asset Global Investments Co., Ltd. Vaxcyte, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 13,264 shares of PCVX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,264
Previous 15,011
11.64%
Holding current value
$1.15 Million
Previous $1.71 Million
36.66%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding PCVX
# of Institutions
354Shares Held
123MCall Options Held
772KPut Options Held
430K-
Vanguard Group Inc Valley Forge, PA11.4MShares$990 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$945 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$860 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$752 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$424 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.13B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...